Inactive Instrument

Nova Pharma Solutions Share Price

NPS

MYL03006O003

Latest news: Nova Pharma Solutions

03-06	Nova Pharma Solutions Berhad Announces Appointment of Gan Yee Hin as Executive Director, Effective March 6, 2026	CI
02-27	Southern Score Builders Berhad completed the acquisition of additional 26.56% stake in Nova Pharma Solutions Berhad.	CI
02-09	Nova Pharma Solutions Berhad Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01-29	Nova Pharma Solutions Berhad Announces Change in Financial Year End	CI
12-21	Southern Score Builders Berhad acquired 33% stake in Nova Pharma Solutions Berhad from Khoo Boo Wie for MYR 18.2 million.	CI
11-21	Nova Pharma Solutions Berhad Announces First Interim Single-Tier Dividend of 8 Sen for the Financial Year Ending 31 December 2025, Payable on December 26, 2025	CI
25/08/25	Nova Pharma Solutions Berhad Reports Earnings Results for the Half Year Ended June 30, 2025	CI
24/02/25	Nova Pharma Solutions Berhad Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25/11/24	Nova Pharma Solutions Berhad Announces First Interim Single Tier Dividend for the Financial Year Ending 31 December 2024, Payable on 27 December 2024	CI
26/08/24	Nova Pharma Solutions Berhad Reports Earnings Results for the Half Year Ended June 30, 2024	CI
22/02/24	Nova Pharma Solutions Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	CI
17/08/23	Nova Pharma Solutions Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2023, Payable on 15 September 2023	CI
16/08/23	Nova Pharma Solutions' Profit, Revenue Rise in H1	MT

More news

Managers and Directors: Nova Pharma Solutions

Manager	Title	Age	Since
Boo Wie Khoo CEO	Chief Executive Officer	56	31/03/2015
Ammar Mokhtar SAM	Sales & Marketing	-	-
Sue Ching Leong SEC	Corporate Secretary	-	-

Director	Title	Age	Since
Boo Wie Khoo BRD	Director/Board Member	56	31/03/2015
Leong Tah Ter BRD	Director/Board Member	49	31/12/2014
Tik Hwa Ng BRD	Director/Board Member	-	30/06/2020

More insiders

Other Construction & Engineering

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NOVA PHARMA SOLUTIONS	+43.75%	-14.81%	-	-	7.67M
QUANTA SERVICES, INC.	+3.99%	-0.16%	+36.54%	+264.29%	87.02B
VINCI	-0.32%	+1.21%	-7.75%	+5.06%	67.08B
LARSEN & TOUBRO LIMITED	+3.68%	+4.13%	-3.05%	+31.10%	53.16B
COMFORT SYSTEMS USA, INC.	+4.24%	-4.47%	+36.46%	+645.82%	45.01B
FERROVIAL N.V.	+0.25%	+9.43%	-11.05%	+75.36%	39.24B
HOCHTIEF AG	-0.68%	+1.23%	+48.24%	+293.96%	31.96B
EMCOR GROUP, INC.	+1.95%	-3.17%	-9.90%	+230.32%	29.39B
CHINA STATE CONSTRUCTION ENGINEERING CORPORATION LIMITED	0.00%	+1.10%	-20.21%	-12.26%	28.38B
ACS, ACTIVIDADES DE CONSTRUCCIÓN Y SERVICIOS, S.A.	-0.71%	+0.22%	+25.29%	+170.15%	27.2B
Average	+5.60%	+0.51%	+10.51%	+189.31%	45.38B
Weighted average by Cap.	+1.78%	+0.11%	+12.41%	+189.65%

See all sector performances

Nova Pharma Solutions Berhad is a Malaysia-based company, which is engaged in the business of provision of technical documentation, validation, and project execution in the pharmaceutical and biological industries. It operates through four segments: Design, Post Design, engineering, procurement, construction, and commissioning (EPCC) and Other Support. The Design segment comprise conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipmentâ€™s. The Post Design segment comprise tendering and procurement support as well as construction management of plant. The EPCC segment comprise of works and services pertaining to engineering, procurement, construction, and commissioning for advanced technology facilities. The Other Support segment comprise of services to assist customer in the manufacturing practice document review and gap analysis and assessment.

Employees

Sector

Construction & Engineering

More about the company